Position in NKTR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,173,675
+$5,371,472 QoQ
Shares Held
102,760
+310.3% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Mar 31, 2022CallValue
$109,417
CallShares
1,353
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. NKTR ranks #49 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in NKTR
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,173,675 | 102,760 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $1,802,203 | 25,048 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,512,651 | 35,777 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $173,373 | 3,047 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $179,251 | 6,937 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $84,153 | 123,756 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $128,010 | 137,647 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $169,158 | 130,122 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $49,785 | 40,150 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $72 | 78 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $200,319 | 357,714 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $46,786 | 77,978 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $2,159 | 3,724 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $60,911 | 87,017 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $292,889 | 129,597 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $427,768 | 133,678 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $674,066 | 177,386 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $109,417 | 20,300 | Call | Defined | 2022-05-12 | |
| 2022-03-31 | $1,062,228 | 197,074 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,617,011 | 119,690 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,098,900 | 61,186 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,569,880 | 91,485 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,312,360 | 65,618 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,917,668 | 112,804 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $1,373,600 | 80,800 | Put | Defined | 2021-02-11 | |
| 2020-12-31 | $697,000 | 41,000 | Call | Defined | 2021-02-11 | |
| 2020-09-30 | $1,318,905 | 79,500 | Put | Defined | 2020-11-12 | |
| 2020-09-30 | $336,777 | 20,300 | Call | Defined | 2020-11-12 | |
| 2020-09-30 | $1,996,107 | 120,320 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,296,180 | 185,500 | Put | Defined | 2020-08-12 | |
| 2020-06-30 | $1,088,520 | 47,000 | Call | Defined | 2020-08-12 | |
| 2020-06-30 | $3,500,144 | 151,129 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,600,345 | 201,700 | Put | Defined | 2020-05-12 | |
| 2020-03-31 | $928,200 | 52,000 | Call | Defined | 2020-05-12 | |
| 2020-03-31 | $2,945,978 | 165,041 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||